• OPEN AN ACCOUNT
Indian Indices
Nifty
25,003.05 252.15
(1.02%)
Sensex
82,188.99 746.95
( 0.92%)
Bank Nifty
56,578.40 817.55
( 1.47%)
Nifty IT
37,294.85 186.90
( 0.50%)
Global Indices
Nasdaq
42,779.54 438.80
(1.04%)
Dow Jones
6,020.48 60.18
(1.01%)
Hang Seng
37,687.53 133.04
(0.35%)
Nikkei 225
8,837.91 26.87
(0.30%)
Forex
USD-INR
85.77 -0.09
(-0.10%)
EUR-INR
97.89 0.03
(0.03%)
GBP-INR
116.15 -0.09
(-0.08%)
JPY-INR
0.59 0.00
(-0.69%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
868.3164333
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
25.72
44869.93
EPS(TTM)
Face Value()
Div & Yield %
61.81
1
0.16
 

As on: Jun 06, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,590.00 4.90 31634 25.72
Stock Price Details
Open Price() 1,576.65
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,597.90
Today's Low () 1,563.25
52-Week High () 1830.05
152-Week Low () 1161.35
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.16
Eps 61.81
Book Value 868.3164333
Market Cap (.Cr) 44,869.93
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE935A01035


News
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
Glenmark Pharmaceuticals reports consolidated net profit of Rs 4.65 crore in the March 2025 quarter
Board of Glenmark Pharmaceuticals recommends final dividend
Glenmark Pharmaceuticals grants 1.19 lakh stock options under ESOS
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark Pharmaceuticals announces board meeting date
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Trading Window
More
Corporate Details
Incoporation Year   : 1977
Chairman : Glenn Saldanha
Bussiness Group : Indian Private
Registered Office
Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40189999
Fax:91-22-40189986
Fax:91-22-66317458
E-Mail : complianceofficer@glenmarkpharma.com
URL : http://www.glenmarkpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • BSE Shariah 50
  • MIDCAP 200
  • CNX 500
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi